Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: An investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled study-Reference-Cited by-同舟云学术

Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: An investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled study

Published:2006 Issue:5 Volume:54 Page:1401-1409
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Hetland Merete Lund,Stengaard-Pedersen Kristian,Junker Peter,Lottenburger Tine,Ellingsen Torkell,Andersen Lis Smedegaard,Hansen Ib,Skjødt Henrik,Pedersen Jens Kristian,Lauridsen Ulrik Birk,Svendsen Anders,Tarp Ulrik,Pødenphant Jan,Hansen Gert,Lindegaard Hanne,Carvalho Anselmo De,ØStergaard Mikkel,Hørslev-Petersen Kim,

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference31 articles.

1. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: A five-year randomized followup trial

2. Guidelines for the management of rheumatoid arthritis: 2002 Update

3. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis

Cited by 153 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vitamin D, Immune Function, and Atherosclerosis. Where Are We Now?;Nutrition Research;2024-07

2. Long-term efficacy of a 2-year MRI treat-to-target strategy on disease activity and radiographic progression in patients with rheumatoid arthritis in clinical remission: 5-year follow-up of the IMAGINE-RA randomised trial;RMD Open;2024-03

3. Treating rheumatoid arthritis;JAAPA;2023-09

4. Remission, response, retention and persistence to treatment with disease-modifying agents in patients with rheumatoid arthritis: a study of harmonised Swedish, Danish and Norwegian cohorts;RMD Open;2023-09

5. Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial;Annals of the Rheumatic Diseases;2023-07-09